BioPharmaTrend
News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
  • Interviews
  • Business Intelligence
  • Case Studies
Intelligence
  • Business Intelligence
  • Case Studies
  • Lab
  • Membership
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
This company is included in Intelligence Lab

Emulate

Emulate logo

Website
https://emulatebio.com/
Founded
2013

Founded in 2013, Emulate is a Boston-based company developing organ-on-a-chip systems for various research and drug discovery purposes. By now, they raised a total $224.3M from multiple investors, with the last $82M Series E round led by Northpond Ventures.
Emulate has multiple organ-on-a-chips in their portfolio, specializing on a deeper understanding of the organ function itself, rather than the complex interplay of multiple organs. With the chips for kidney, liver, lung, brain and more, the company claims to effectively predict toxicology profiles or inflammatory responses for the patients. For example, the brain chip contains 5 cell types, forming the human neuro-vascular unit model, which is representative for the blood-brain barrier, cell microenvironment and multicellular diversity.


Articles Mentioning This Company

How Industry Embraces Organ-on-Chips: A 2024 Status Report

April 17, 2024     Business Intelligence
Report highlights: We are currently at an exciting juncture where several big pharmaceutical companies have started adopting such models and conducted several exploratory studies The last 4 years have witnessed at least twofold increase in industrial validation of organ-on-chips across various fields and organ models The majority of the studies …

R&D Platform

The major application fields defined by Emulate include ADME-Tox, infectious diseases, immunology & inflammation, microbiome and more. For example, using an organ-on-a-chip system helped to study Shigella infection, since the mechanical forces have an essential role in the disease's pathogenesis, hence the chip system could become a highly representative model compared to conventional in vitro models.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • Business Intelligence
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Lab Access
  • Lab Membership
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.